Negativní kontrola
negativ ah 00012554 963 [B] SS INT / lgEA647 FL4
H: 35,74%
—i—
1c03
Iv. ioJ:
SS IMT
Pozitivní kontrola
negativ a h 00012554 963 [H]
IgE A647 FL4 / CD63 FITC
<a
I-+:	I+-: 2,941b
0,00%	
	
I--: 0,00%	"}+-: 97,06%
1c;
id? id*
lgEA647 FL4
!0*
negativ a h 00012554 963 [H]
IgE A647 FL4 / CD203c P E
J-+: 0,00%		J++:1,76%
		
		0
J--: 0,00%		J+-: 98,14%
1c;
id* id?
lgEA647 FL4
1c4
1C4-
pozitiv ah 00012553 962 [B] SS INT / lgEA647 FL4
Včela
K: 13,15%
—i—
1000 (xlO3)
SS INT
pozitiv ah 00012553 962 [K]
IgE A647 FL4 / CD63 FITC
c
ID1-!.
L-+:	L++: 28,76%	
0,00%	. ■' ' ľ"	
	r " ■_. -	LU Q,
		u
		Q
		a
L-:		
0,00%	L+-: 71,24%	
1c;
id4 id?
lgEA647 FL4
1c4
10S
so5
pozitiv ah 00012553 962 [K]
IgE A647 FL4 / CD203c P E
!ir-
M-^: 0,0095	M++: 19,28%
	
	Ä
Ní—z 0,00%	W-: 80,72%
1c;
id4 id?
lgEA647 FL4
1c4
včela ah 00012555 964 [B] SS INT / lgEA647 FL4
1000
(xió3)
SSINT
Vosa
vosa ah 00012556 965 [B] SSINT / IgEA647FL4
ssim~
1000
(xlO3)
■i
so*
1c3-
vcela ah 00012555 964 [N]
IgE A647 FL4 / CD63 FITC
0-+: I	0++:	57,14%.
0,00%		
		
O-:		
0,00%	0+-:	42,86%
io3      iq" ia= lgEA647 FL4
1c4
1c''-
vosa ah 00012556 965 [Q]
IgE A647 FL4 / CD63 FITC
IR-:	R++: 0,66%
:o,oo%	
1	
-	
	'"■sil
:R-:	
:0,00%	.- R+-: 99,34%
1c;
t 1c"
1c1
lgEA647 FL4
1c4
so*
včela ah 00012555 964 [N]
IgE A647 FL4 / CD203c P E
3 m*-
P-+: 0,00%		P+i-: 35,00%
		
		.
P--: 2,14%		P+-: 62,86%
iť      ir la11 lgEA647 FL4
1c4
-
-
!0* 1c-
vosa ah 00012556 965 [Q]
IgE A647 FL4 / CD203c P E
ÍS-+: 0,00%	5++-: 0,49%
-	
_ i	
	
i	\
S-: 3,2fl% .......i .....	V-: 96,23% "i ........i ........
io3      io< ia= lgEA647 FL4
1c4